Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 709
Selected: 0
NCT IDTitle
NCT01617447A Short Treatment Study of Aripiprazole in Pediatric Patients With Autistic Disorder
NCT00657176An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors
NCT04189705A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis
NCT05066724Efficacy of Centanafadine SR as a Potential Smoking Cessation Treatment
NCT00095511Aripiprazole in Patients With Acute Mania
NCT01091337Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency Room
NCT01710709Open-label Study to Evaluate the Effectiveness of an Intramuscular Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients With Bipolar I Disorder
NCT03376763MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics
NCT02050854Open-Label Observational Pilot Study to Evaluate the Pharmacokinetics of Aripiprazole in Subjects With Bipolar 1 Disorder or Schizophrenia
NCT01050530A Trial to Investigate the Efficacy of OPC-41061 Administered at a Dose of 7.5 mg in Patients With Hepatic Edema
NCT04092686A Clinical Trial That Will Study the Efficacy and Safety of an Investigational Drug in Acutely Psychotic People With Schizophrenia
NCT00362271Aripiprazole and Effexor XR Drug Interaction Study
NCT01141400The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy Use
NCT02964273Safety, Pharmacokinetics, Tolerability and Efficacy of Tolvaptan in Children and Adolescents With ADPKD (Autosomal Dominant Polycystic Kidney Disease)
NCT02477670Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia
NCT00665366Study to Evaluate the Efficacy and Safety of Aripiprazole Administered With Lithium or Valproate Over 12 Weeks in the Treatment of Mania in Bipolar I Disorder
NCT03568500A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic
NCT01795105ABF Tourette's Disorder Post Marketing Surveillance Study
NCT03620981Brexpiprazole for the Treatment of Patients With Agitation Associated With Dementia of the Alzheimer's Type
NCT02223715Prospective Observational Study of Clostridium Difficile Infection in Asian Pacific Countries
NCT01413178A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
NCT04030143A Trial of Multiple-doses of Aripiprazole in Adults With Schizophrenia or Bipolar 1 Disorder
NCT01726816Efficacy and Safety Study of Probucol in Patients With Diabetic Nephropathy
NCT06114628Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
NCT03605836A Trial to Evaluate the Efficacy, Safety, and Tolerability of Centanafadine Sustained-release Tablets in Adults With Attention-deficit/Hyperactivity Disorder
NCT01973140Effects of Tolvaptan in Healthy Adults
NCT01801930A Phase 1 Study of OCV-C02 in Patients With Advanced or Relapsed Colorectal Cancer
NCT01000467Pharmacokinetics Study for Probucol
NCT03510663Phase I Study of OPC-61815
NCT02105272Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
NCT03427892Brexpiprazole for Bipolar Depression
NCT03643159A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder
NCT00463151An Exploratory Study of Rebamipide in Patients With Active Ulcerative Colitis
NCT06926829A Long-term Trial of EB-1020 in Adult Patients With ADHD
NCT02068352A Study to Evaluate the Effectiveness and Safety of Topical OPA-15406 Ointment to Treat Participants With Atopic Dermatitis
NCT02848521A Study Measuring Quality of Life, Treatment Preference and Satisfaction of ADPKD Patients in Europe
NCT05848700A Clinical Study to Learn if SEP-363856 Has Physical Dependence in Adults With Schizophrenia
NCT00094432A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode
NCT04182958A Phase I, Open-Label Trial to Assess the Absorption, Metabolism, and Excretion of (14C)-OPC-61815 in Healthy Male Japanese Subjects
NCT07166796a Phase I PK Study in Healthy Male Subjects. 2 Groups of Healthy Male Subjects
NCT00876343Study of Aripiprazole as an Adjunctive Therapy in Patients With Major Depressive Disorder
NCT07086313A Trial to Evaluate the Efficacy and Safety of EB-1020 in Pediatric Patients With ADHD
NCT01856634Pharmacokinetic and Safety Trial to Determine the Appropriate Dose for Pediatric Patients With Multidrug Resistant Tuberculosis
NCT01014416Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy Male
NCT01723904A Phase 3b, Open-Label, Safety and Efficacy Study of Rotigotine as Add-On Therapy With Low Doses of Pramipexole or Ropinirole in Patients With Advanced Parkinson's Disease
NCT01959035Aripiprazole Once-monthly in Patients With Schizophrenia
NCT05687071A Long-term Trial of ETC-1002 in Patients With Hyper-LDL Cholesterolemia
NCT02219009Open-label Study to Assess Usability of the Medical Information Device #1 (MIND1) System in Adults With Schizophrenia On Oral Aripiprazole
NCT01683058Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia
NCT04100096A Trial of Brexpiprazole in the Treatment of Borderline Personality Disorder